Cargando…

Bioinformatics analysis of high frequency mutations in myelodysplastic syndrome-related patients

BACKGROUND: Myelodysplastic syndrome (MDS) is a group of hematological malignancies that may progress to acute myeloid leukemia (AML). Bioinformatics-based analysis of high-frequency mutation genes in MDS-related patients is still relatively rare, so we conducted our research to explore whether high...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Kun, Nie, Bo, Li, Liyin, Yang, Xin, Yang, Jinrong, He, Zhenxin, Li, Yanhong, Cheng, Shenju, Shi, Mingxia, Zeng, Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573449/ https://www.ncbi.nlm.nih.gov/pubmed/34805353 http://dx.doi.org/10.21037/atm-21-4094

Ejemplares similares

MicroRNA-18a-5p regulates the Warburg effect by targeting hypoxia-inducible factor 1α in the K562/ADM cell line
por: Wu, Kun, et al.
Publicado: (2021)

CD20-negative primary middle ear diffuse large B-cell lymphoma coexpressing MYC and BCL-2 secondary to acute lymphoblastic leukemia: A case report
por: Ding, Chao, et al.
Publicado: (2019)

PB2013: THE FREQUENCY, EVOLUTION AND SIGNIFICANCE OF GENE MUTATION IN MYELODYSPLASTIC SYNDROMES WITH NORMAL KARYOTYPE
por: Xu, Feng, et al.
Publicado: (2023)

Bioinformatics gene analysis of potential biomarkers and therapeutic targets of osteoarthritis associated myelodysplastic syndrome
por: Xin, Peicheng, et al.
Publicado: (2023)

The Frequency of SF3B1 Mutations in Thai Patients with Myelodysplastic Syndrome
por: Rujirachaivej, Punchita, et al.
Publicado: (2018)

Identification of microRNA-regulated pathways using an integration of microRNA-mRNA microarray and bioinformatics analysis in CD34+ cells of myelodysplastic syndromes
por: Xu, Feng, et al.
Publicado: (2016)

Gene mutation spectrum of patients with myelodysplastic syndrome and progression to acute myeloid leukemia
por: Liu, Ming, et al.
Publicado: (2021)

Somatic mutations predict prognosis in myelodysplastic syndrome patients with normal karyotypes
por: Zeng, Xiangzong, et al.
Publicado: (2021)

Screening and identification of key candidate genes and pathways in myelodysplastic syndrome by bioinformatic analysis
por: Le, Ying
Publicado: (2019)

Myelodysplastic syndrome transforming to atypical chronic myeloid leukemia shows changes in its mutation allele frequency and acquisition of new mutations
por: NM, Hakim, et al.
Publicado: (2021)

Implications of mutational spectrum in myelodysplastic syndromes based on targeted next-generation sequencing
por: Xu, Yuanyuan, et al.
Publicado: (2017)

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
por: Malcovati, Luca, et al.
Publicado: (2011)

The yin-yang of immunity: Immune dysregulation in myelodysplastic syndrome with different risk stratification
por: Peng, Xiaohuan, et al.
Publicado: (2022)

Somatic mutations of activating signalling, transcription factor, and tumour suppressor are a precondition for leukaemia transformation in myelodysplastic syndromes
por: Xu, Feng, et al.
Publicado: (2022)

U2AF1 Mutations in Chinese Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome
por: Qian, Jun, et al.
Publicado: (2012)

Spliceosome mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia
por: Chesnais, Virginie, et al.
Publicado: (2012)

Mutation Analysis of the WT1 Gene in Myelodysplastic Syndromes
por: Hosoya, Noriko, et al.
Publicado: (1998)

Whole-exome and targeted sequencing identify ROBO1 and ROBO2 mutations as progression-related drivers in myelodysplastic syndromes
por: Xu, Feng, et al.
Publicado: (2015)

Summary of animal models of myelodysplastic syndrome
por: Li, Weisha, et al.
Publicado: (2021)

Recurrent DNMT3A Mutations in Patients with Myelodysplastic Syndromes
por: Walter, Matthew J., et al.
Publicado: (2011)

Prognostic significance of U2AF1 mutations in myelodysplastic syndromes: a meta-analysis
por: Li, Bixia, et al.
Publicado: (2019)

Somatic mutations predict outcomes of hypomethylating therapy in patients with myelodysplastic syndrome
por: Jung, Seung-Hyun, et al.
Publicado: (2016)

Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms
por: Montalban-Bravo, Guillermo, et al.
Publicado: (2018)

Comparison and Implications of Mutational Profiles of Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: A Meta-Analysis
por: Wan, Ziqi, et al.
Publicado: (2020)

DHX9-mediated pathway contributes to the malignant phenotype of myelodysplastic syndromes
por: Huang, Nanfang, et al.
Publicado: (2023)

TP53 mutation variant allele frequency is a potential predictor for clinical outcome of patients with lower-risk myelodysplastic syndromes
por: Belickova, Monika, et al.
Publicado: (2016)

Prognostic impact of gene mutations in myelodysplastic syndromes with ring sideroblasts
por: Martín, Iván, et al.
Publicado: (2017)

Isocitrate Dehydrogenase Mutations in Myelodysplastic Syndromes and in Acute Myeloid Leukemias
por: Testa, Ugo, et al.
Publicado: (2020)

Impact of single versus multiple spliceosome mutations on myelodysplastic syndrome
por: Nagehan, Pakasticali, et al.
Publicado: (2023)

Myelodysplastic syndromes
por: Hellström Lindberg, Eva
Publicado: (2018)

The inflammatory cytokine profile of myelodysplastic syndromes: A meta-analysis
por: Shi, Xin, et al.
Publicado: (2019)

Dynamics of epigenetic regulator gene BCOR mutation and response predictive value for hypomethylating agents in patients with myelodysplastic syndrome
por: Li, Xiao, et al.
Publicado: (2021)

Mutation status and burden can improve prognostic prediction of patients with lower‐risk myelodysplastic syndromes
por: Jiang, Lingxu, et al.
Publicado: (2019)

Case Report: A novel WRN mutation in Werner syndrome patient with diabetic foot disease and myelodysplastic syndrome
por: Peng, Huifang, et al.
Publicado: (2022)

Recurrent DNMT3A R882 Mutations in Chinese Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome
por: Lin, Jiang, et al.
Publicado: (2011)

Prognostic role of TET2 deficiency in myelodysplastic syndromes: A meta-analysis
por: Lin, Yun, et al.
Publicado: (2017)

Abnormal Ferroptosis in Myelodysplastic Syndrome
por: Lv, Qi, et al.
Publicado: (2020)

Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome
por: Al-Kali, Aref, et al.
Publicado: (2023)

Novel spontaneous myelodysplastic syndrome mouse model
por: Li, Weisha, et al.
Publicado: (2021)

P728: EVALUATION OF IPSS-M IN PATIENTS WITH MYELODYSPLASTIC SYNDROME AND SPLICEOSOME MUTATIONS
por: Urrutia, Samuel, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3rjmubj8eeqp95qj58a92qpgoe